American Academy of Child and Adolescent Psychiatry 59th Annual Meeting Program Schedule
Please note that this schedule is subject to change.

New Research Poster Presentation 5.25
Maintenance of Efficacy of Lisdexamfetamine Dimesylate: Results From Two Randomized-Withdrawal Studies in Adults and in Children and Adolescents with ADHD
Friday, October 26, 2012
Liza A. Squires, M.D., Shire Development LLC, Wayne, PA
Maria Gasior, M.D., Ph.D., Shire Development LLC, Wayne, PA
Tobias Banaschewski, M.D., Ph.D., Department of Child and Adolescent Psychiatry, Mannheim, Germany
Mats Johnson, M.D., Child Neuropsychiatry Unit, Göteborg, Sweden
Alessandro Zuddas, M.D., Child Neuropsychiatry, Dept. Neuroscience, University of Cagliari, Cagliari, Italy
Michel Lecendreux, M.D., Pediatric Sleep Center, Hôpital Robert Debré, Paris, France
Ralph Bloomfield, MSC, Shire Pharmaceuticals, Inc., Basingstoke, United Kingdom
David Coghill, M.D., F.R.C.Psych., MBChB, Division of Neuroscience, Ninewells Hospital, Dundee, Scotland
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.